Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Cypros seeks broad international patent coverage for CPC-111

Sep. 27, 1996

Tyrosine kinase inhibitors from Warner-Lambert

Sep. 27, 1996

Bayer investigates agents for arteriosclerosis, restenosis

Sep. 27, 1996

Novel free radical scavengers reported by Merrell

Sep. 27, 1996

Improved dopaminergic agents from Zambon for cardiovascular disorders

Sep. 27, 1996

Dual ACE/NEP inhibitors from ADIR

Sep. 27, 1996

Mitsui's Na+/H+-exchange inhibitors for cardiovascular disorders

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...